Cargando…

Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol

INTRODUCTION: Renal cell carcinoma (RCC) is the most common neoplasm in adult kidneys. One of the most important unmet medical needs in RCC is a prognostic biomarker to enable identification of patients at high risk of relapse after nephrectomy. New biomarkers can help improve diagnosis and hence th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rasti, Arezoo, Mehrazma, Mitra, Madjd, Zahra, Keshtkar, Abbas Ali, Roudi, Raheleh, Babashah, Sadegh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716203/ https://www.ncbi.nlm.nih.gov/pubmed/26729387 http://dx.doi.org/10.1136/bmjopen-2015-009667

Ejemplares similares

SMAD4 Expression in Renal Cell Carcinomas Correlates With a Stem-Cell Phenotype and Poor Clinical Outcomes
por: Rasti, Arezoo, et al.
Publicado: (2021)

Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics
por: Saeednejad Zanjani, Leili, et al.
Publicado: (2019)

Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas
por: Rasti, Arezoo, et al.
Publicado: (2018)

Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol
por: Gheytanchi, Elmira, et al.
Publicado: (2017)

The role of CircRNA/miRNA/mRNA axis in breast cancer drug resistance
por: Ghazimoradi, Mohammad H., et al.
Publicado: (2022)

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)

Circulating cancer stem cell markers in breast carcinomas: a systematic review protocol
por: Mansoori, Maryam, et al.
Publicado: (2017)

Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549
por: Roudi, Raheleh, et al.
Publicado: (2013)

Potential theranostics of circulating tumor cells and tumor-derived exosomes application in colorectal cancer
por: Vafaei, Somayeh, et al.
Publicado: (2020)

Diagnostic role of circulating MiR-21 in colorectal cancer: a update meta-analysis
por: Liu, Tong, et al.
Publicado: (2020)

Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis
por: Gheytanchi, Elmira, et al.
Publicado: (2023)

Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer
por: Kalantari, Elham, et al.
Publicado: (2022)

MiR-21 and let-7 cooperation in the regulation of lung cancer
por: Bai, Jinquan, et al.
Publicado: (2022)

Plasma exosomal miR-320d, miR-4479, and miR-6763-5p as diagnostic biomarkers in epithelial ovarian cancer
por: Wang, Shiwen, et al.
Publicado: (2022)

Potential of miR-21 to Predict Incomplete Response to Chemoradiotherapy in Rectal Adenocarcinoma
por: Ourô, Susana, et al.
Publicado: (2020)

High expression of DNA damage-inducible transcript 4 (DDIT4) is associated with advanced pathological features in the patients with colorectal cancer
por: Fattahi, Fahimeh, et al.
Publicado: (2021)

MiR-21-5p Induces Pyroptosis in Colorectal Cancer via TGFBI
por: Jiang, Rilei, et al.
Publicado: (2021)

Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus
por: Hezova, Renata, et al.
Publicado: (2015)

MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma
por: Vychytilova-Faltejskova, Petra, et al.
Publicado: (2015)

A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma
por: Mo, Xiaocong, et al.
Publicado: (2022)

Circulating Exosomal miR-150-5p and miR-99b-5p as Diagnostic Biomarkers for Colorectal Cancer
por: Zhao, Ya jing, et al.
Publicado: (2019)

Identification of Target PTEN-Based miR-425 and miR-576 as Potential Diagnostic and Immunotherapeutic Biomarkers of Colorectal Cancer With Liver Metastasis
por: Hu, Xiaoyun, et al.
Publicado: (2021)

Do statins improve outcomes for patients with non-small cell lung cancer? A systematic review and meta-analysis protocol
por: Li, Feng, et al.
Publicado: (2018)

Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
por: Wu, Jianing, et al.
Publicado: (2022)

Up-regulation of miR-381 inhibits NAD+ salvage pathway and promotes apoptosis in breast cancer cells
por: Bolandghamat Pour, Zahra, et al.
Publicado: (2019)

Comparing the accuracy of quantitative versus qualitative analyses of interim PET to prognosticate Hodgkin lymphoma: a systematic review protocol of diagnostic test accuracy
por: Procházka, Vít, et al.
Publicado: (2016)

Milk thistle nano-micelle formulation promotes cell cycle arrest and apoptosis in hepatocellular carcinoma cells through modulating miR-155-3p /SOCS2 /PHLDA1 signaling axis
por: Rahnama, Saghar, et al.
Publicado: (2023)

miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer
por: Nielsen, Boye Schnack, et al.
Publicado: (2014)

Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin
por: Bolandghamat Pour, Zahra, et al.
Publicado: (2019)

Diagnostic accuracy and prognostic significance of Glypican-3 in hepatocellular carcinoma: A systematic review and meta-analysis
por: Jiang, Donglei, et al.
Publicado: (2022)

Up-regulation of miR-155 potentiates CD34+ CML stem/progenitor cells to escape from the growth-inhibitory effects of TGF-ß1 and BMP signaling
por: Mahdloo, Touba, et al.
Publicado: (2021)

WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P/miR-628/SMAD3 axis
por: Wei, Yu-Bo, et al.
Publicado: (2022)

Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells
por: Pakravan, Katayoon, et al.
Publicado: (2022)

Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma
por: Monfared, Hamideh, et al.
Publicado: (2019)

MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
por: Hong, Yinghui, et al.
Publicado: (2021)

CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma
por: Lv, Jiancheng, et al.
Publicado: (2021)

Prognostication in palliative radiotherapy—ProPaRT: Accuracy of prognostic scores
por: Maltoni, Marco, et al.
Publicado: (2022)

miR-93, miR-373, and miR-17-5p Negatively Regulate the Expression of TBP2 in Lung Cancer
por: Li, Ye, et al.
Publicado: (2020)

Plasma-Derived Exosome MiR-19b Acts as a Diagnostic Marker for Pancreatic Cancer
por: Wang, Lei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_852dos9eo4vj9hloolm5hf29fm